 |
MorphoSys AG
MOR
|
18.2 |
- |
2.43 % |
$ 254 M |
Germany |
 |
ARCA biopharma
ABIO
|
28.8 |
- |
1052.0 % |
$ 415 M |
USA |
 |
Aeterna Zentaris
AEZS
|
5.72 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Albireo Pharma
ALBO
|
28.5 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Aileron Therapeutics
ALRN
|
2.13 |
- |
10.36 % |
$ 9.8 M |
USA |
 |
I-Mab
IMAB
|
0.68 |
- |
- |
$ 866 M |
China |
 |
Genfit SA
GNFT
|
3.36 |
- |
2.54 % |
$ 160 B |
France |
 |
Biophytis SA
BPTS
|
0.33 |
- |
-13.47 % |
$ 169 M |
France |
 |
Ascendis Pharma A/S
ASND
|
216 |
$ 220.01 |
2.07 % |
$ 5 B |
Danmark |
 |
Aptinyx
APTX
|
0.14 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Midatech Pharma plc
MTP
|
0.29 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
26.7 |
$ 19.69 |
2.39 % |
$ 920 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 |
- |
- |
$ 26.5 M |
USA |
 |
BioMarin Pharmaceutical
BMRN
|
61 |
$ 55.38 |
2.38 % |
$ 10.6 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 |
- |
- |
$ 7.46 M |
Israel |
 |
AgeX Therapeutics
AGE
|
13 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Acorda Therapeutics
ACOR
|
13.5 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Atreca
BCEL
|
1.27 |
- |
-11.76 % |
$ 5.79 M |
USA |
 |
Acasti Pharma
ACST
|
3.37 |
- |
4.01 % |
$ 150 M |
Canada |
 |
BeiGene, Ltd.
BGNE
|
185 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
bluebird bio
BLUE
|
0.61 |
- |
- |
$ 546 M |
USA |
 |
Cara Therapeutics
CARA
|
1 |
- |
-3.03 % |
$ 260 M |
USA |
 |
Adverum Biotechnologies
ADVM
|
3.86 |
- |
- |
$ 86.2 M |
USA |
 |
Acer Therapeutics
ACER
|
0.77 |
- |
2.71 % |
$ 14 M |
USA |
 |
Advaxis
ADXS
|
0.31 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Avenue Therapeutics
ATXI
|
0.42 |
- |
-52.27 % |
$ 4.45 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
1.66 |
$ 1.35 |
1.89 % |
$ 344 M |
Britain |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
9.55 |
$ 8.24 |
0.67 % |
$ 110 M |
USA |
 |
CRISPR Therapeutics AG
CRSP
|
48.8 |
$ 47.3 |
1.87 % |
$ 4.25 B |
Schweiz |
 |
Cyclacel Pharmaceuticals
CYCC
|
0.25 |
- |
-5.98 % |
$ 34.1 M |
USA |
 |
CytomX Therapeutics
CTMX
|
6.75 |
$ 4.39 |
3.42 % |
$ 606 M |
USA |
 |
ChemoCentryx
CCXI
|
26.9 |
- |
- |
$ 3.74 B |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
13.3 |
- |
- |
$ 2.02 B |
USA |
 |
BioDelivery Sciences International
BDSI
|
3.1 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Enochian Biosciences
ENOB
|
0.7 |
- |
- |
$ 40.5 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 |
- |
- |
$ 1.01 B |
USA |
 |
CureVac N.V.
CVAC
|
19.3 |
- |
- |
$ 867 M |
Germany |
 |
Eton Pharmaceuticals
ETON
|
20.8 |
$ 24.37 |
6.1 % |
$ 656 M |
USA |
 |
Bellerophon Therapeutics
BLPH
|
8.23 |
- |
-74.18 % |
$ 955 K |
USA |
 |
Akero Therapeutics
AKRO
|
48.4 |
- |
- |
$ 3.67 B |
USA |
 |
Arbutus Biopharma Corporation
ABUS
|
4.42 |
$ 4.54 |
5.29 % |
$ 870 M |
Canada |
 |
Homology Medicines
FIXX
|
1.33 |
- |
0.77 % |
$ 53.4 M |
USA |
 |
Akouos
AKUS
|
5.34 |
- |
0.23 % |
$ 488 M |
USA |
 |
AIkido Pharma
AIKI
|
3.17 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Allakos
ALLK
|
1.31 |
- |
- |
$ 28.6 M |
USA |
 |
Brickell Biotech
BBI
|
2.11 |
- |
-5.38 % |
$ 6.06 M |
USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
4.4 |
- |
- |
$ 384 M |
Britain |